Skip to main content
. 2022 Oct 21;14(10):2250. doi: 10.3390/pharmaceutics14102250

Figure 3.

Figure 3

Schematic diagram of the activation of NF-κB and MAPK pathways by MTA treatment. Reprinted/adapted with permission from Ref. [23]. 2018, Yu, J.